Viro Perspectives
Learn more on the topic of Varicella Zoster Virus (VZV) via our ongoing series of clinical posts by David Kilpatrick, PhD and Abbas Vafai, PhD.
Nicholas Vafai a, Kevin Self b, Bret Sheffield b, Sally Hojvat c, Aubrey Kusi-Appiah a, Patrick Vaughan b, Elliot Cowan c, Abbas Vafai a a Viro Research, 2326 Wisteria Drive, Suite 220, Snellville, GA 30078, United States of America b DCN Diagnostics, 3193 Lionshead Avenue, Carlsbad, CA 92010, United States of America c Partners in […]
INTRODUCTION: Varicella-zoster virus (VZV) infection disproportionally affects people with HIV (PWH), primarily presenting as herpes zoster. The clinical outcomes remain understudied, in terms of VZV seroprevalence in this population. In this report, the authors assessed the VZV seroprevalence, rates of VZV illness, and associated health care costs in a large cohort of PWH over 20 […]
INTRODUCTION: Herpes zoster (HZ) is caused by the reactivation of the varicella-zoster virus (VZV) which leads to the development of a painful, vesicular rash and can cause complications such as postherpetic neuralgia (PHN) and vision loss. HZ is increasing globally, costing billions annually to the healthcare system and to society through loss of productivity. HZ […]